StonvexLoading…
StonvexStonvexStonvexCore line items from SSTK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $989.92M | $935.26M | $874.59M | $827.83M |
Operating Income | $75.06M | $68.71M | $68.40M | $93.62M |
Net Income | $45.50M | $35.93M | $110.27M | $76.10M |
EPS (Diluted) | $1.25 | $1.01 | $3.04 | $2.08 |
Total Assets | $1.36B | $1.31B | $1.04B | $881.18M |
Total Liabilities | $774.90M | $790.81M | $508.92M | $433.70M |
Cash & Equivalents | $178.24M | $111.25M | $100.49M | $115.15M |
Free Cash Flow OCF − CapEx | $123.83M | $-14.57M | $95.91M | $115.16M |
Shares Outstanding | 35.53M | 34.87M | 35.57M | 35.83M |